Investigating how specific proteins in the eye affect retinal health and diseases like retinitis pigmentosa.
Role of Interphotoreceptor Matrix Proteoglycans in Retinal Homeostasis and Retinitis Pigmentosa
This study is looking at how two proteins, IMPG1 and IMPG2, help keep the retina healthy and how problems with these proteins might lead to retinitis pigmentosa, a condition that can cause vision loss, especially in children, and it aims to find ways to treat these issues with gene therapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | West Virginia University NIH-funded |
| Lab location | 1 site (Morgantown, United States) |
| Project ID | NIH-10945359 on NIH RePORTER |
What this research studies
This research focuses on the role of two proteins, IMPG1 and IMPG2, in maintaining the health of the retina and their connection to retinitis pigmentosa, a condition that can lead to blindness. By using specially designed mouse models, the study will explore how these proteins facilitate nutrient exchange between the retina and the retinal pigment epithelium, which is crucial for visual function. The research will also investigate the mechanisms behind childhood-onset retinitis pigmentosa linked to mutations in these proteins and assess potential gene therapy strategies to address these issues.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with retinitis pigmentosa, particularly those with known mutations in the IMPG1 or IMPG2 genes.
Not a fit: Patients with retinal diseases not linked to mutations in IMPG1 or IMPG2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for retinitis pigmentosa and improve the understanding of retinal diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of extracellular matrix proteins in retinal health, suggesting that this approach could yield valuable insights.
Where this research is happening
Morgantown, United States
- West Virginia University — Morgantown, United States (Active)
Researchers
- Principal investigator: Salido, Ezequiel Martin — West Virginia University
- Study coordinator: Salido, Ezequiel Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.